Pharmacokinetics of a liposomal formulation of doxorubicin in rats
Background: Measuring free drug concentration following systemic administration of a liposomal drug is a crucial aspect of the assessment of its in vivo behavior. Therefore we require an efficient method to separate free drug in the plasma from encapsulated drug. Objectives: To study the pharmacokin...
Saved in:
Main Authors: | Zongyu Liu (Author), Ye Bi (Author), Yating Sun (Author), Fei Hao (Author), Jiahui Lu (Author), Qingfan Meng (Author), Robert J. Lee (Author), Yaping Tian (Author), Jing Xie (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparison between liposomal and nonliposomal formulations of doxorubicin in the treatment of cancer: An updated review
by: Yik Hoe Ngan, et al.
Published: (2016) -
Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting
by: Jihoon Lee, et al.
Published: (2023) -
A Pegylated Liposomal Platform: Pharmacokinetics, Pharmacodynamics, and Toxicity in Mice Using Doxorubicin as a Model Drug
by: Wan-Liang Lu, et al.
Published: (2004) -
Liposomal Vitamin D<sub>3</sub> as an Anti-aging Agent for the Skin
by: Ye Bi, et al.
Published: (2019) -
Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology
by: Sihem Ait-Oudhia, et al.
Published: (2014)